Maximum Fidelity Surgical Simulations has filed a notice of an exempt offering of securities to raise $2,249,998.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Maximum Fidelity Surgical Simulations is raising up to $2,249,998.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Robert Mills played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Maximum Fidelity Surgical Simulations
Maximum Fidelity Surgical Simulations (MaxFi) specializes in the reanimation of human and animal cadavers for the purposes of surgical modeling. Our patented envivoPC technology reconstitutes the cadavers circulatory system with a realistic warm pulsatile flow, avoiding tissues distortion and bloating associated with other cadaver perfusion attempts. We work alongside physicians and medical device companies to design the best models possible for surgical education and extending the applicability of cadavers. We place engineers in the physicians seat and maximize physicians confidence in the medical devices efficacy. We are the intersection of innovation and precision in surgical simulation, reshaping the landscape of medical training and device development. Message us to learn more about what we do! .
To learn more about Maximum Fidelity Surgical Simulations, visit http://max-fi.com/
Maximum Fidelity Surgical Simulations Linkedin Page: https://www.linkedin.com/company/max-fi/
Contact:
Robert Mills, Chief Executive Officer
573-447-8694
https://www.linkedin.com/in/robertgmillsstl/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.